BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34808091)

  • 1. Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines.
    Adams C; Jadi R; Segovia-Chumbez B; Daag J; Ylade M; Medina FA; Sharp TM; Munoz-Jordan JL; Yoon IK; Deen J; Lopez AL; de Silva AM; Premkumar L
    Emerg Infect Dis; 2021 Dec; 27(12):3073-3081. PubMed ID: 34808091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Evidence of Widespread Zika Transmission across the Philippines.
    Biggs JR; Sy AK; Brady OJ; Kucharski AJ; Funk S; Tu YH; Reyes MAJ; Quinones MA; Jones-Warner W; Ashall J; Avelino FL; Sucaldito NL; Tandoc AO; Cutiongco-de la Paz E; Capeding MRZ; Padilla CD; Hibberd ML; Hafalla JCR
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.
    Salgado BB; Maués FCJ; Jordão M; Pereira RL; Toledo-Teixeira DA; Parise PL; Granja F; Souza HFS; Yamamoto MM; Chiang JO; Martins LC; Boscardin SB; Lalwani JDB; Vasconcelos PFC; Proença-Modena JL; Lalwani P
    Int J Infect Dis; 2023 Apr; 129():142-151. PubMed ID: 36736575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas.
    Nascimento EJM; Bonaparte MI; Luo P; Vincent TS; Hu B; George JK; Áñez G; Noriega F; Zheng L; Huleatt JW
    Am J Trop Med Hyg; 2019 Sep; 101(3):708-715. PubMed ID: 31392955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria.
    Asaga Mac P; Tadele M; Airiohuodion PE; Nisansala T; Zubair S; Aigohbahi J; Anyaike C; Velayudha R; Kroeger A; Panning M
    Ann Med; 2023 Dec; 55(1):652-662. PubMed ID: 37074313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Rapid Active Sampling Surveys Demonstrated a Rapidly Changing Zika Seroprevalence among Children in a Rural Dengue-endemic Region in Southwest Guatemala during the Zika Epidemic (2015-2016).
    Lamb MM; Paniagua-Avila A; Zacarias A; Rojop N; Chacon A; Natrajan MS; Waggoner JJ; Lopez MR; Cordon-Rosales C; Huleatt JW; Bonaparte MI; Asturias EJ; Olson D
    Am J Trop Med Hyg; 2022 Nov; 107(5):1099-1106. PubMed ID: 36252798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based assay discriminates Zika virus infection from other flaviviruses.
    Balmaseda A; Stettler K; Medialdea-Carrera R; Collado D; Jin X; Zambrana JV; Jaconi S; Cameroni E; Saborio S; Rovida F; Percivalle E; Ijaz S; Dicks S; Ushiro-Lumb I; Barzon L; Siqueira P; Brown DWG; Baldanti F; Tedder R; Zambon M; de Filippis AMB; Harris E; Corti D
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8384-8389. PubMed ID: 28716913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.